These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9175687)
1. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Faden D; Tincani A; Tanzi P; Spatola L; Lojacono A; Tarantini M; Balestrieri G Eur J Obstet Gynecol Reprod Biol; 1997 May; 73(1):37-42. PubMed ID: 9175687 [TBL] [Abstract][Full Text] [Related]
3. Poor pregnancy outcome and anticardiolipin antibodies. De Carolis S; Caruso A; Ferrazzani S; Carducci B; De Santis L; Mancuso S Fetal Diagn Ther; 1994; 9(5):296-9. PubMed ID: 7818777 [TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Matthiesen L; Berg G; Ernerudh J; Skogh T Am J Reprod Immunol; 1995 Jan; 33(1):31-9. PubMed ID: 7619232 [TBL] [Abstract][Full Text] [Related]
5. beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Katano K; Aoki A; Sasa H; Ogasawara M; Matsuura E; Yagami Y Hum Reprod; 1996 Mar; 11(3):509-12. PubMed ID: 8671255 [TBL] [Abstract][Full Text] [Related]
6. Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome. Oron G; Ben-Haroush A; Goldfarb R; Molad Y; Hod M; Bar J J Matern Fetal Neonatal Med; 2011 Apr; 24(4):606-9. PubMed ID: 20874430 [TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy. Valdés-Macho E; Cabiedes J; Villa AR; Cabral AR; Alarcón-Segovia D Arch Med Res; 2002; 33(5):460-5. PubMed ID: 12459316 [TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Lee RM; Emlen W; Scott JR; Branch DW; Silver RM Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478 [TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Lee RM; Brown MA; Branch DW; Ward K; Silver RM Obstet Gynecol; 2003 Aug; 102(2):294-300. PubMed ID: 12907102 [TBL] [Abstract][Full Text] [Related]
11. Anti-prothrombin antibodies are associated with adverse pregnancy outcome. Marozio L; Curti A; Botta G; Canuto EM; Salton L; Tavella AM; Benedetto C Am J Reprod Immunol; 2011 Nov; 66(5):404-9. PubMed ID: 21682791 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets. Ferrer-Oliveras R; Llurba E; Cabero-Roura L; Alijotas-Reig J Lupus; 2012 Mar; 21(3):257-63. PubMed ID: 22065091 [TBL] [Abstract][Full Text] [Related]
13. A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Matthiesen LS; Berg G; Ernerudh J; Skogh T Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):21-6. PubMed ID: 10221605 [TBL] [Abstract][Full Text] [Related]
14. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Yasuda M; Takakuwa K; Tokunaga A; Tanaka K Obstet Gynecol; 1995 Oct; 86(4 Pt 1):555-9. PubMed ID: 7675379 [TBL] [Abstract][Full Text] [Related]
15. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Avcin T; Ambrozic A; Bozic B; Accetto M; Kveder T; Rozman' B Clin Exp Rheumatol; 2002; 20(1):101-8. PubMed ID: 11892692 [TBL] [Abstract][Full Text] [Related]